During the forecast period, Natus Medical, Inc. (US), Compumedics Limited (Australia), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), and Masimo Corporation (US), are the Leading Players in the global Epilepsy Monitoring Devices Market.
The global epilepsy monitoring devices market is projected to reach USD 615 million by 2026 from USD 489 million in 2021, at a CAGR of 4.7% during the forecast period. The growth in this market is driven by the increasing incidence and prevalence of epilepsy, growing preference for ambulatory healthcare and increasing use of wearables, growing demand for continuous monitoring, and the rising awareness of neurodegenerative diseases, including epilepsy.
Natus Medical, Inc. (US), Compumedics Limited (Australia), The Magstim Co. Ltd. (UK), Nihon Kohden Corporation (Japan), and Masimo Corporation (US) were the top players in the epilepsy monitoring devices market during the forecast period. Other major players in the market include Empatica, Inc. (US), Medtronic Plc (Ireland), Boston Scientific Corporation (US), Drägerwerk AG & Co. KGaA (Germany), mjn Neuroserveis S.L. (Spain), Abbott Laboratories, Inc. (US), LivAssured B.V. (Netherlands), BioSerenity (France), Aleva Neurotherapeutics (Switzerland), Medpage, Ltd. (UK), Neurosoft (Russia).
To know about the assumptions considered for the study download the pdf brochure
Natus Medical, Inc. is a leading company in the epilepsy monitoring devices market. The company’s broad product portfolio is its key strength. The company’s Neuro business segment offers a comprehensive line of neurodiagnostic, neurocritical care, and neurosurgical products. It also has a strong geographic presence across North America, Latin America, Europe, and Asia. The company derives most of its revenue from North America, specifically the US. To leverage the growth opportunities in the epilepsy monitoring devices market, the company focuses on adopting inorganic growth strategies. In this regard, in May 2020, the company partnered with Holberg EEG AS (Norway) to expand its EEG product portfolio.
Compumedics, Ltd. is a well-established global brand in the epilepsy monitoring devices market, with operations across the globe. It has a robust portfolio of epilepsy monitoring products. The company offers epilepsy monitoring systems through its Sleep Diagnostics and Neuro Diagnostics segments. Through its two subsidiaries, Compumedics has a broad international reach that spans the Americas, Australia and the Asia Pacific, and Europe and the Middle East. The company provides its products via an established international network of distributors and direct sales offices. Compumedics works closely with each of its distributors to identify customer needs and provide optimal service and support to both the distributors and the ultimate user of the product.
Nihon Kohden Corporation is a key player in the global epilepsy monitoring devices market. The company’s major product lines include patient monitors, electroencephalographs, evoked potential & electromyograph systems, electrocardiographs, defibrillators, nerve monitoring systems, and hematology analyzers. The company provides EEG and EMG systems through its Physiological Measuring Equipment business segment. Nihon Kohden operates in the US, Canada, Japan, Germany, China, India, and Turkey. The company adopted product launches as its dominant strategy to gain a competitive edge in Japan as well as international markets. In March 2018, Nihon Kohden launched the AIREEG WEE-1200 wireless EEG system, which is designed for long-term epilepsy monitoring, intensive care, and routine EEG environments.
Masimo Corporation (US) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, medical devices, and a wide array of sensors. It provides solutions for improving patient outcomes and reducing the cost of patient care. The company offers its solutions to hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physicians’ offices, veterinarians, and consumers through a direct sales force, distributors, and original equipment manufacturers (OEMs). The company mainly operates in North and South America, the US, Europe, the Middle East, Asia, and Australia.
The Magstim Co, Ltd. (UK) recently acquired Electrical Geodesics, inc. (EGI) from Royal Philips to from Magstim EGI. The company’s portfolio consists of neuromodulation products, including transcranial magnetic stimulators (TMS), magnetic stimulator coils, neuronavigation tools, tDCS (transcranial direct current stimulation) stimulators, EEG (electroencephalograph) systems and accessories, and interoperative products such as Sonowand neuroimaging and navigation systems. The Magstim EGI subsidiary offers the company’s EEG related products.
Related Reports:
Epilepsy Monitoring Devices Market by Product (Conventional & Wearable Devices, Standard EEG, Video EEG, Ambulatory EEG, EMG, MEG, Deep Brain Stimulation Devices) End User (Hospitals, Neurology Centres, ASC, Home Care Settings) - Global Forecast to 2026
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
